News
-
-
COMMUNIQUÉ DE PRESSE
Inside Information / Other news releases
Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders -
-
COMMUNIQUÉ DE PRESSE
Informations privilégiées / Autres communiqués
SSCL obtient une extension de contrat de plus de 300M£ pour fournir des services essentiels au gouvernement britannique pendant trois années supplémentaires. Sopra Steria et SSCL renforcent leur position sur le marché britannique avec un nouvel accord de 3 ans -
-
-
COMMUNIQUÉ DE PRESSE
Acquisition or disposal of the issuer's own shares / Description of the buyback program
Eurofins launches sixth buy-back programme of its own shares with plans to repurchase up to 4.5% of share capital. Programme starting on 25 April 2025 aims to hedge Long-Term Incentive plans and support other financial initiatives -
-
COMMUNIQUÉ DE PRESSE
Xlife Sciences AG publishes 2024 Annual Report: Strategic Expansion, Technological Milestones, and International Capital Market Presence
Xlife Sciences AG publishes 2024 Annual Report highlighting strategic partnerships, technological milestones, and dual listing plans on SIX and LSE to enhance international market presence -
